Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Ramprasath, Vanu R ^a,b   Eyal, Inbal ^c   Zchut, Sigalit ^c   Jones, Peter Jh ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Enzymotec Ltd   (Israel)

Author keywords

Fatty acids; Fish oil; Human; Krill oil; Omega 3 index

Indexed keywords

CORN OIL; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KRILL OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OIL; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOAVAILABILITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; FATTY ACID ANALYSIS; FEMALE; HUMAN; KRILL; LIPID ANALYSIS; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EUPHAUSIACEA; ZEA MAYS;

ADULT; ANIMALS; CHOLESTEROL, HDL; CORN OIL; CROSS-OVER STUDIES; DIETARY FATS, UNSATURATED; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; EUPHAUSIACEA; FEMALE; FISH OILS; HEALTHY VOLUNTEERS; HUMANS; MALE; TRIGLYCERIDES;

EID: 84889046143     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-178     Document Type: Article

References (51)

1. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM, Lancet 1989 2 757 761 2571009 (Pubitemid 19234807)
2. The omega-3 index as a risk factor for coronary heart disease. Harris WS, Am J Clin Nutr 2008 87 1997S 2002S 18541601 (Pubitemid 351872681)
3. Fish consumption and risk of stroke in men. He K, Rimm EB, Merchant A, Rosner BA, Stampfer MJ, Willett WC, Ascherio A, JAMA 2002 288 3130 3136 10.1001/jama.288.24.3130 12495393 (Pubitemid 36014130)
4. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P, Circulation 2004 109 2705 2711 10.1161/01.CIR.0000132503.19410.6B 15184295 (Pubitemid 38737914)
5. Nutrition C: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association, Circulation 2002 106 2747 2757 10.1161/01.CIR.0000038493.65177.94 12438303 (Pubitemid 35364932)
6. Fish consumption and coronary heart disease mortality: A systematic review of prospective cohort studies. Marckmann P, Gronbaek M, Eur J Clin Nutr 1999 53 585 590 10.1038/sj.ejcn.1600832 10477243 (Pubitemid 29396562)
7. Krill for human consumption: nutritional value and potential health benefits. Tou JC, Jaczynski J, Chen YC, Nutr Rev 2007 65 63 77 17345959 (Pubitemid 351804381)
8. Krill oil: Monograph. Monograph, Altern Med Rev 2010 15 84 86 20359272
9. Comparative effects of dietary corn, fish and krill oils on intestinal glycosylation. Ruggiero-Lopez D, Servetto C, Lopez E, Lenoir D, Alallon W, Biol MC, Louisot P, Martin A, Biochem Mol Biol Int 1994 33 1001 1010 7987247 (Pubitemid 24255523)
10. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, Hubacher R, Rains TM, Nutr Res 2009 29 609 615 10.1016/j.nutres.2009.09.004 19854375
11. Evaluation of the effects of neptune krill oil on the clinical course of hyperlipidemia. Bunea R, El Farrah K, Deutsch L, Altern Med Rev 2004 9 420 428 15656713 (Pubitemid 40066715)
12. Evaluation of the effect of neptune krill oil on chronic inflammation and arthritic symptoms. Deutsch L, J Am Coll Nutr 2007 26 39 48 10.1080/07315724.2007.10719584 17353582 (Pubitemid 46411395)
13. Evaluation of the effects of neptune krill oil on the management of premenstrual syndrome and dysmenorrhea. Sampalis F, Bunea R, Pelland MF, Kowalski O, Duguet N, Dupuis S, Altern Med Rev 2003 8 171 179 12777162 (Pubitemid 36676184)
14. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Wijendran V, Huang MC, Diau GY, Boehm G, Nathanielsz PW, Brenna JT, Pediatr Res 2002 51 265 272 10.1203/00006450-200203000-00002 11861929 (Pubitemid 34174960)
15. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Kidd PM, Altern Med Rev 2007 12 207 227 18072818 (Pubitemid 47613220)
16. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. Batetta B, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Sanna F, Bisogno T, Uda S, et al. J Nutr 2009 139 1495 1501 10.3945/jn.109.104844 19549757
17. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, Berge K, Vik H, Pedersen JI, Lipids 2011 46 37 46 10.1007/s11745-010-3490-4 21042875
18. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations-a comparative bioavailability study of fish oil vs. krill oil. Schuchardt JP, Schneider I, Meyer H, Neubronner J, von Schacky C, Hahn A, Lipids Health Dis 2011 10 145 10.1186/1476-511X-10-145 21854650
19. Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Banni S, Carta G, Murru E, Cordeddu L, Giordano E, Sirigu AR, Berge K, Vik H, Maki KC, Di Marzo V, Griinari M, Nutr Metab (Lond) 2011 8 7 10.1186/1743-7075-8-7 21276269
20. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Griffin BA, Curr Opin Lipidol 2008 19 57 62 10.1097/MOL.0b013e3282f2e2a8 18196988
21. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the nutrition committee of the American heart association. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, et al. Stroke 2000 31 2751 2766 10.1161/01.STR.31.11.2751 11062305
22. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon diet heart study. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N, Circulation 1999 99 779 785 10.1161/01.CIR.99.6.779 9989963 (Pubitemid 29083018)
23. Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Wood DA, Riemersma RA, Butler S, Thomson M, Macintyre C, Elton RA, Oliver MF, Lancet 1987 1 177 183 2880015 (Pubitemid 17008190)
24. The relation between fish consumption, death from all causes, and incidence of coronary heart disease. the NHANES I Epidemiologic Follow-up Study. Gillum RF, Mussolino M, Madans JH, J Clin Epidemiol 2000 53 237 244 10.1016/S0895-4356(99)00149-3 10760632 (Pubitemid 30173241)
25. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ, J Am Coll Cardiol 1995 25 387 394 10.1016/0735-1097(94)00370-6 7829792
26. Treatment of EFA deficiency with dietary triglycerides or phospholipids in a murine model of extrahepatic cholestasis. Werner A, Havinga R, Kuipers F, Verkade HJ, Am J Physiol Gastrointest Liver Physiol 2004 286 822 832 10.1152/ajpgi.00425.2003 14670824 (Pubitemid 38506815)
27. Dietary krill increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese zucker rats. Di Marzo V, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Bisogno T, Collu M, Betetta B, Uda S, Berge K, Banni S, International Dairy Journal 2010 20 231 235 10.1016/j.idairyj.2009.11.015
28. Age dependent incorporation of 14C-DHA into rat brain and body tissues after dosing various 14C-DHA-esters. Graf BA, Duchateau GS, Patterson AB, Mitchell ES, van Bruggen P, Koek JH, Melville S, Verkade HJ, Prostaglandins Leukot Essent Fatty Acids 2010 83 89 96 10.1016/j.plefa.2010.05.004 20580213
29. Intestinal absorption of long-chain polyunsaturated fatty acids in preterm infants fed breast milk or formula. Carnielli VP, Verlato G, Pederzini F, Luijendijk I, Boerlage A, Pedrotti D, Sauer PJ, Am J Clin Nutr 1998 67 97 103 9440382 (Pubitemid 28037632)
30. The Omega-3 Index: a new risk factor for death from coronary heart disease? Harris WS, Von Schacky C, Prev Med 2004 39 212 220 10.1016/j.ypmed. 2004.02.030 15208005 (Pubitemid 38797975)
31. Altered erythrocyte n-3 fatty acids in Mediterranean patients with coronary artery disease. Paganelli F, Maixent JM, Duran MJ, Parhizgar R, Pieroni G, Sennoune S, Int J Cardiol 2001 78 27 32 10.1016/S0167-5273(00)00442-3 11259810 (Pubitemid 32232134)
32. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M, J Lipid Res 1997 38 2012 2022 9374124 (Pubitemid 27468010)
33. Risk stratification by the " EPA + DHA level " and the " EPA/AA ratio " focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids. Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B, Herz 2004 29 673 685 10.1007/s00059-004-2602-4 15580322 (Pubitemid 40064639)
34. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J, N Engl J Med 2002 346 1113 1118 10.1056/NEJMoa012918 11948270 (Pubitemid 34984601)
35. Cardiovascular risk and the omega-3 index. von Schacky C, Harris WS, J Cardiovasc Med (Hagerstown) 2007 8 Suppl 1 46 49 10.2459/01.JCM.0000289273. 87803.87 17876200 (Pubitemid 47429083)
36. n-3 fatty acids and serum lipoproteins: human studies. Harris WS, Am J Clin Nutr 1997 65 1645S 1654S 9129504 (Pubitemid 27187958)
37. N-3 fatty acids: food or supplements? Kris-Etherton PM, Hill AM, J Am Diet Assoc 2008 108 1125 1130 10.1016/j.jada.2008.04.025 18589017 (Pubitemid 351853123)
38. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. Harris WS, J Lipid Res 1989 30 785 807 2677200 (Pubitemid 19167302)
39. Beneficial effects by intake of Euphausiacea pacifica on high-fat diet-induced obesity. Sadzuka Y, Sugiyama I, Miyashita M, Ueda T, Kikuchi S, Oshiro E, Yano A, Yamada H, Biol Pharm Bull 2012 35 568 572 10.1248/bpb.35.568 22466562
40. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. GISSI-Prevenzione Investigators, Lancet 1999 354 447 455 10465168
41. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A, Am J Clin Nutr 1997 66 649 659 9280188 (Pubitemid 27366792)
42. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ, Am J Clin Nutr 2000 71 1085 1094 10799369 (Pubitemid 30230554)
43. The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. Schwellenbach LJ, Olson KL, McConnell KJ, Stolcpart RS, Nash JD, Merenich JA, J Am Coll Nutr 2006 25 480 485 10.1080/07315724.2006.10719562 17229894 (Pubitemid 46175663)
44. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Kris-Etherton PM, Harris WS, Appel LJ, Nutrition C, Arterioscler Thromb Vasc Biol 2003 23 20 30 10.1161/01.ATV.0000038493.65177.94 12588785
45. Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Contacos C, Barter PJ, Sullivan DR, Arterioscler Thromb 1993 13 1755 1762 10.1161/01.ATV.13.12.1755 8241095 (Pubitemid 23360561)
46. Influence of an algal triacylglycerol containing docosahexaenoic acid (22: 6n-3) and docosapentaenoic acid (22: 5n-6) on cardiovascular risk factors in healthy men and women. Sanders TA, Gleason K, Griffin B, Miller GJ, Br J Nutr 2006 95 525 531 10.1079/BJN20051658 16512939
47. Combination of phytosterols and omega-3 fatty acids: a potential strategy to promote cardiovascular health. Normen L, Shaw CA, Fink CS, Awad AB, Curr Med Chem Cardiovasc Hematol Agents 2004 2 1 12 10.2174/1568016043477323 15320801 (Pubitemid 38854964)
48. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY, Clin Chem 2006 52 2265 2272 10.1373/clinchem.2006.072322 17053155 (Pubitemid 44925001)
49. Techniques for the measurement of visceral fat: a practical guide. van der Kooy K, Seidell JC, Int J Obes Relat Metab Disord 1993 17 187 196 8387967 (Pubitemid 23133348)
50. A simple method for the isolation and purification of total lipides from animal tissues. Folch J, Lees M, Sloane Stanley GH, J Biol Chem 1957 226 497 509 13428781
51. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502 4337382